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Economic growth and cancer incidence
ABSTRACT
Why do we observe increasing rates of new cancer cases? Is the increasing burden of
cancer mainly the outcome of higher life expectancy and better life conditions brought about
by economic development? To what extent do environmental degradation and changes in life-
styles play a relevant role? To answer these questions, we empirically assessed the
relationship between per capita income and new cancer cases (incidence) by using cross-
sectional data from 122 countries
We found that the incidence rate of all-sites cancer increases linearly with per capita
income, even after controlling for population ageing, improvement in cancer detection, and
omitted spatially correlated variables. If higher incidence rates in developed countries were
merely due to those factors, and not also to life-styles and environmental degradation, we
would have found a flat or even an inverted-U pattern between per capita income and cancer
incidence. 
The regression analysis was applied also to the eight most common site-specific cancers.
This confirmed the existing evidence on the different patterns in rich and poor countries,
explained the pattern of the estimated relationship for aggregate cancers, and gave some other
interesting insights.
KEYWORDS: Economic development; Cancer; Environmental Kuznets Curve; Environmental
degradation; Spatial error models.
Highlights
 New cancer cases increase with p.c. income in a cross-section of 122 countries.
 Improved detection potential and a longer life alone cannot explain this evidence.
 Bad life-styles and environmental degradation play a relevant role.
1. Introduction
Cancer incidence (yearly new cases of cancer) is increasing and predicted to grow fast. The
term ‘Cancer epidemic’ has become frequently used, not only by the media (e.g. Servan-
Schreiber, 2008), but also by academic journals and by the World Health Organization1. The
1 In April 2015, the Lancet Oncology and The Lancet launched a joint campaign against cancer “to inform strategies to control
the global cancer epidemic” (see http://www.thelancet.com/campaigns/cancer).  In 2005 the term ‘epidemic’ was used in the 58 th 
resolution of the WH assembly, see http://www.who.int/mediacentre/news/releases/2005/pr_wha05/en/
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problem is particularly alarming in lower- and middle-income countries (see, e.g., Boyle and
Levin 2008; GLOBOCAN 2012; Stewart and Wild 2014; Vineis and Wild 2014;  Ferlay et al.
2015; Torre et al. 2015). For some rich countries, incidence rates are stabilizing (or slightly
decreasing), however at very high rates. In the USA, this has been the case since the mid 1990s
(Siegel et al. 2016). 
Although data availability on cancer has increased significantly in the last years2, the
relationship between cancer incidence and economic development remains largely
unexplored, with just a few exceptions, namely: Beaulieu et al. 2009, Bray et al. 2012, Fidler et
al. 2016.3 The first is a report by “The Economist” Intelligence Unit on the health and economic
burden of cancer. As a supplementary result, in one of its appendices, the report shows the
outcome of a multiple regression analysis aimed at understanding cross-country variations in
both estimated cancer incidence rates for 2009, and in fatality rates for 2002. Regressors
included p.c. income, per cent of population aged 65+, and regional dummies. The authors
found a positive association of higher cancer incidence rates with both age and higher per
capita income countries, which they attributed to the belief of “underreporting of cancer cases
in developing countries” (Beaulieu et al., 2009, 62).   
Bray et al. (2012) and Fidler et al. (2016) grouped countries according to the four levels
(low, medium, high, and very high) of the Human Development Index (HDI) and compared
incidence and mortality rates across groups. Both articles brought support in favour of the so-
called “cancer-transition”, according to which the demographic transition and economic
development are changing the composition of the different types of cancers, with a shift from
cancers linked to infections to those associated with non-infectious risk factors and possibly
associated with the “western” lifestyle.
The above-mentioned papers are in line with the health literature, briefly summarised in
the next section. The general idea is that increasing cancer incidence rates might be the
outcome of economic development, which delivered not only higher life expectancy and
improved cancer detection and statistical reporting, but also environmental degradation and
“bad” life-styles. 
The aim of our research was to empirically investigate the macro level relationship
between cancer incidence rates and per capita income. For this purpose, we tested some
reduced models that looked only at the ends of the complicated causal chains. Such an
approach has been followed by the so-called Environmental Kuznets Curve (EKC) literature
2 For an assessment of the status of population-based cancer registries worldwide see (Bray et al., 2015).
3 The differences between the present research and the previously mentioned studies will be discussed in section 5.
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that has been investigating the relationship between economic growth and the environment
for more than 25 years (e.g., Stern 2004, Dinda 2004, Luzzati 2015). While the EKC literature
focused on anthropic pressures, e.g. emissions, here we focused on one possible outcome of
pressures, that is, cancer occurrence.  
The paper is structured as follows. The second section outlines the links between
cancer and economic development, from which we derived the conceptual model for our
empirical analysis (Figure 1). The third section describes data and methods. In the fourth
section results are presented and discussed. The last section gives our conclusions. 
2. Cancer and its possible links with economic development
This section firstly summarises what we know about cancer genesis, and then why
economic development can play a major role in cancer occurrence. The dominant theory
explaining cancer is the so-called Somatic Mutation Theory (SMT) (Nowell 1976; Hanahan and
Weinberg 2000 and 2011) according to which “random mutations in the genes which control
proliferation or apoptosis are responsible for cancer” (Bertram 2001, p. 170). Hence, cancer is
due to stochastic (relevant) mutations that occur in oncogenes and tumour suppressor genes
(Lodish et al. 2000). The older a person, the higher is the number of accumulated stochastic
mutations, which ultimately leads to higher probability of cancer occurrence. 
Recently, SMT has been criticised on the basis of theoretical reasons and experimental
and epidemiological evidence. Hence, other theories of carcinogenesis have begun to gain
ground. They shift the focus from single cells to the entire tissue and attribute a prominent
role to altered environments (epigenetic signals) for regulating gene expression, rather than
to stochastic mutations of DNA (see e.g. Burgio and Migliore, 2015). For instance, Tissue
Organisation Field Theory (TOFT) (see e.g. Baker 2015), which is better seen as integrative
rather than alternative to SMT (Bedessem and Ruphy, 2015), looks promising for
understanding the role of low-dose foetal exposure to ubiquitous and long lived chemical
pollutants, namely the endocrine-disrupting chemicals (EDCs)1. These chemicals, by
mimicking physiologic hormone signalling molecules, perturbate tightly regulated
intercellular signalling pathways. This leads to subtle architectural changes in tissue
organization that increase the risk of cancer development. (Howard and Stats 2013).
Overall, cancer is increasingly seen as the disruption of a complex equilibrium, that is,
the outcome of an evolutionary process in which random genetic mutations have to face the
selection of environmental pressure; moreover, intrinsic epigenetic plasticity, clonal evolution
1 A useful introduction to EDCs is Gore et al. (2014).
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and high cellular adaptability are also crucial (Greaves, 2014).  Hence, cancer is acknowledged
as stemming from many interacting factors, that is, from mutations in oncogenes and tumour
suppressor genes, from genetic inheritance2, work and living environment, and lifestyles (see
e.g. Belpomme et al. 2007a, Belpomme et al 2007b, Stewart and Wild 2014). 
Many studies have investigated the differential contribution to cancer incidence of non-
genetic risk factors (e.g. Danaei et al. 2005) and of environmental factors (e.g., Alavanja 2003,
Boffetta 2006, Mannucci et al. 2015, Stare and Jozefowicz 2008). The confluence of diverse
types of evidence increasingly indicates the relevance of involuntary exposure to
environmental contaminants, which affect particularly the “developing foetus, the developing
child and adolescent” (Newby and Howard, 2005, 57). For instance, there is evidence of
decrease in the average age of cancer onset (e.g. Newby et at. 2007) and increase in childhood
cancers (e.g. Steliarova-Foucher et al. 2004), which are also attributed to environmental
factors (Stewart and Wild, 2014; Norman et al., 2014). Historical evidence supports the idea
that cancer is a disease of industrialization/wealth since “in preindustrial societies, the death
rate in infancy was high, but if adolescence was reached then [...] the chances of living a
reasonable life span in good health were high and unlikely to end in the development of
cancer” (Howard and Statts, 2013).  It is not under dispute that economic and technological
progress led to the introduction of a complex mixture of persistent xeno-chemicals and other
pollutants that have been recognised as carcinogenic. 
Aggregate quantifications of the environmental risk factors have been proposed in a
wide–ranging report by the World Health Organization that surveys the findings on the
environmental risk factors (Prüss-Üstün, 2016). According to this report, household and
ambient air pollution, passive tobacco smoking, radiation, chemicals, and occupational risks
are responsible for at least 20% of cancer cases (in terms of disability-adjusted life years)
(Prüss-Üstün, 2016, XVI, 50, and 86). 
Of course, any estimate is highly uncertain (and incomplete) because of the complexity
of the cancer-environment relationship in which polluting agents are often time persistent
and pervasive, bio-accumulate and are bio-magnificated along the food chain, performing
multiple biological actions as well as acting in synergy with other substances. Because of this
complexity, we believe that it is also useful to tackle the issue with a very coarse grained
perspective, empirically investigating to what extent economic development as a whole plays a
role in cancer incidence. To this end, we performed a regression analysis in which income per
2 The heritable factors have an important, but not exclusive, role. For instance, using data from Swedish, Danish and Finnish
twin registries, it has been reported (Lichtenstein et al 2000) that genetic influence on the incidence of cancer explains no
more that 42% of the variance in incidence rate, depending on the cancer site.
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capita proxies the joint effects of environmental factors and life-styles on cancer incidence.
The reasons why income per capita is expected to be a significant regressor of cancer
incidence come from analysing the major links of the causal chain that goes from income to
cancer, which are described in what follows and summarised by Figure 1. 
Figure 1: From income to cancer incidence: major links
Economic development started with the industrial revolution and was literally fuelled
by fossil fuels (e.g., Smil 2000). The availability of an unprecedented quantity of energy
radically transformed our economy and the relationship between humans and nature, to the
point that many scholars believe that we entered a new epoch, the Anthropocene (Crutzen
2002, Steffen et al 2011). A large amount (and number) of pollutants have populated the
places where we live, resulting in prolonged and pervasive biochemical stresses that have
been found to be risk factors for several diseases, including cancer. Furthermore, other new
risk factors (e.g. excessive-weight and obesity) emerged as an outcome of life-style changes
that have accompanied the economic development process. 
At the same time, material living conditions have generally improved, thereby on the one
hand bringing about an increase in cancer due to higher life expectancy and, on the other,
leading to a reduction in cancers related to some infectious diseases. In other words, income
growth has allowed an epidemiological transition1, that is, a shift “from a predominance of
1 According to the theory of epidemiological transitions (Omran 2005, pp. 737-738), three ages of mortality patterns in
history are observed, namely the age of “pestilence and famine”, of “receding pandemics”, and of “degenerative and man-made
diseases”. In the first “age” life expectancy at birth is very low, but epidemic peaks then become less frequent or disappear,
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cancers linked to infections to cancers associated with risk factors that are mainly non-
infectious and possibly related to the so-called western lifestyle” (Maule and Merletti 2012, p.
745). The identification of this “new epidemiological age” is not only a theoretical construct,
but also a relevant empirical fact. According to the World Health Organization (WHO, 2014)
about 52% of worldwide deaths in 2012 were due to Non-Communicable Diseases (NCDs)
and, of these, about 27% were associated with Malignant Neoplasm. 
As a concluding remark, it has to be considered that part of the observed increase in
cancer incidence along the economic development is the result of improved diagnostic
scrutiny and statistical reporting (e.g. Li et al. 2013, Moynihan et al. 2012). In countries where
health systems are not well developed, cancer statistics collection is poorly organized and the
causes of death often remain undiagnosed resulting in under reporting of cancer deaths in less
developed countries (e.g. Fallah and Kharazmi, 2008). 
3. Material and methods
3.1 The empirical model
The regression model used in this paper is visualised in Figure 1. The items in the
dashed contoured boxes have been controlled for in the regressions, so that the variability of
incidence rates explained by income can be seen as coming from the joint effect of lifestyles
and pollution. The design of the present analysis does not allow a distinction between
lifestyles and environmental risks, the importance of which, however, can be drawn from the
health literature that was briefly summarised above.
Building on the arguments put forward in the previous section, we regressed cancer
incidence rates on the 20-year lagged p.c. income while controlling for (1) population ageing,
(2) potential for detection and statistical reporting, and (3) omitted factors that might be
related to the country’s geographic location. 
Lags in income were used to take into account the long genesis of cancer and its
possible epigenetic nature (see, e.g., Burgio and Migliore, 2015). There are no strong
theoretical reasons for taking a particular time lag. For instance, there seems to be a 30-35
years lag between the peak in tobacco consumption and the peak in the fatality cases of lung
cancer attributable to tobacco smoking (Stewart and Wild 2014, p. 82 ff.; Bilano et al. 2015).
This lag is consistent with a lag of 20 years, or more, when considering cancer occurrence. We
chose a 20 year lag since it was the longest available time period,  due to some lack of older
after which we eventually enter a phase in which mortality tends to approach stability at relatively low levels and non-
communicable diseases, including malignant neoplasms, prevail. 
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data for income. In any case, we also checked for different time lags (none, 5, 10, and 15
years), finding that results do not change qualitatively. This should not be surprising since
income is highly autocorrelated. Hence, from an empirical point of view, the choice of the time
lag has low relevance. In any case, using lagged values for income is important from a
statistical point of view since it avoids potential endogeneity issues.
To control for population ageing, we used average standardised rates since they take
the different age profiles of countries into account (see below). Furthermore, given that the
small size of older age classes in poor countries could cause incidence rates to lose statistical
significance, we did a further check by analysing the age class 40-60 separately.  
Improvements in cancer detection and statistical reporting along the process of
economic development were proxied by physician density (physicians per 1000 inhabitants).
The reasons for choosing this variable are discussed in detail in the next section. 
Many other potential factors (such as genetic risk or diet and habits) can be considered
as strongly related to the geographic location of the country. Those factors have been omitted
since they are either unobservable or lacking in reliable data. A spatial error model was used
to take into account these omitted spatially correlated covariates.
3.2 Estimation methods and techniques
In order to choose the model that best fits the data, papers within the EKC literature
often compare parametric estimates with different specifications of the p.c. income term, i.e.,
linear, quadratic or cubic (see Van Alstine and Neumayer, 2010). We followed a different
approach. As in Luzzati and Orsini (2009) we preliminarily used semi-parametric methods to
assess whether a linear or non-linear specification better fits the data. In the case of evidence
of a linear fit, we used it in the parametric estimates. If semiparametric fits suggested non-
linear patterns, we chose between the quadratic and cubic specification by minimising the
corrected Akaike Information Criterion (AICc) (which also involved maximisation of the
adjusted R-squared). 
For the semiparametric estimates, we used the generalized additive model (GAM), in
which each variable enters nonlinearly and separately. We followed the approach proposed in
Wood (2006), which is based on penalized regression splines, and used the “mgcv package” in
R Development Core Team (2012), with the restricted maximum likelihood (REML) option
(see Wood 2011). 
For the parametric estimates, we followed the spatial econometric methodology
developed by Anselin (1988). The reason behind this choice is that, differently from the
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inclusion of regional dummy variables (as e.g. in Beaulieau et al. 2009), this methodology
explicitly accounts for the effects of spatial correlation due to imperfections in model and
measurements that exhibit a spatial structure, thereby increasing the efficiency of the
parameter estimates.
The spatial correlation can be incorporated in a regression model in different ways. In
the current paper, we used the spatial error model (SEM) in which the spatial correlation is
modelled in the error term. This is based on the a priori grounds that cultural and genetic
factors vary across space and are assumed to drive cancer incidence variability.  However, due
to lack and/or unreliability of data, such factors are unobserved and/or unmeasured and,
therefore, omitted in the regression. If they are influential, then their impact on the
explanation of cancer incidence is subsumed in the error term that shows a spatial pattern. 
To check if this is the case, a spatial specification search was carried out using OLS
estimation and applying a Lagrange Multiplier test. In the presence of evidence of spatial
correlation, the spatial model was estimated by means of maximum likelihood. 
The SEM was implemented by specifying a spatial stochastic process for the error term,
which in turn yields the nonzero correlation for the units that are considered as neighbours.
Consequently, the spatial error model requires the definition of a spatial matrix, which reflects
the potential interactions between neighbouring units (countries in our case). Here, two
different countries are considered as interacting with each other if and only if they belong to
the same region. The region taxonomy was taken from the International Agency for Research
on Cancer, the specialized cancer agency of the World Health Organization (WHO), and is
listed in the appendix. The spatial regressions are estimated using the “spdep package” in R
Development Core Team (2012). 
3.3. Variables
Data on cancer incidence are becoming increasingly reliable due to the diffusion of
national cancer registries (see, e.g., Parkin and Donald 2009). However, cross-national
differences in coverage and quality of the data collected are quite pronounced, resulting in
high variability of both coverage and reliability: thus the quality is often associated with the
level of economic development.  For a worldwide comparison, the most relevant project is
GLOBOCAN, which is today incorporated in “Cancer today”1. GLOBOCAN is a project of the
International Agency for Research on Cancer of the World Health Organization. Its database
contains data for 26 site-specific cancers and for all sites cancer (excluding non-melanoma
1 See http://globocan.iarc.fr/Default.aspx
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skin cancer). This project produced the most recent (2012) estimates of incidence, mortality
and prevalence. 
In order to control for differences arising merely from differences in the age profiles of
each population, the average standardized rates (weighted) - ASR(W) - have to be used. The
standardization procedure (for details see, e.g., Boyle and Parkin 1991) adjusts observed age-
specific rates to a reference population, commonly referred to as the Standard Population,
usually the world population. The term ‘weighted’ refers to standard weights taken from the
population adopted as a standard. We calculated2 ASR(W) using the population weight of the
World Standard Population3 and the population data of the United Nations database. 
The p.c. income variable was the p.c. GDP, expressed in thousands of US$ PPP20114,
taken from the World Bank online database. Income was averaged over three years to mitigate
the effect of the business cycle. As stated previously, we used a 20 year lag to consider the long
genesis of cancer and tested shorter income time lags, which however left results qualitatively
unchanged, as one would expect from the strong autocorrelation of p.c. income (see the
appendix, Table A2).
As regards the variable to proxy the diagnostic potential of a country, it has to be
emphasised that detection and statistical reporting are very different from early detection.
While the first two affect the quality of the incidence rates data, the latter is relevant for
treating cancer, and hence for mortality rates. Early detection is strongly associated with the
presence of screening programmes and diagnostic facilities, which are in turn associated with
high levels of per capita health expenditure (and income). For mere detection and statistical
reporting, however, an easy access to a doctor is a crucial variable, more important than the
availability of advanced technical tools. So far, physician density has proved to be very
important in cancer detection (e.g., Ananthakrishnan et al. 2010, Fleisher et al. 2008, Li et al
2013, Sundmacher and Busse 2011) and for many other care issues, like infant mortality (e.g.,
Farahani et al. 2009), and generally for health outcomes (e.g. Friedberg et al. 2010, Macinko et
al. 2007, Mondal and Shitan 2014, Shi 2012). At the same time, physician density can be
reasonably thought as having “diminishing returns” in cancer incidence reporting, that is, after
2 The database provided by GLOBOCAN already provides ASW(R) rates. Using the data available online and implementing the
procedure described by the Glossary section of GLOBOCAN 2012 (http://globocan.iarc.fr/Pages/glossary.aspx) we obtained
slightly different figures.
3 http://seer.cancer.gov/stdpopulations/world.who.html   World Standard Population is used also in GLOBOCAN 2012.
4 GDP was taken in Power Purchasing Parity (PPP2011) due to the cross-country nature of the analysis. PPP GDP is gross
domestic product converted to international dollars using purchasing power parity rates. An international dollar has the same
purchasing power over GDP as a U.S. dollar has in the United States. Data are in current international dollars based on the
2011 International Comparison Program (ICP).
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some thresholds, further increases in the physician density will have increasingly smaller
relevance. 
For the above reasons, we took physician density as a proxy of cancer incidence
reporting potential and used it in the regressions with a concave specification.  This was
empirically supported by the positive and decreasing marginal impact of physician density on
cancer incidence in preliminary semi-parametric estimates (see, e.g., Figure A2).  Data for
physician density (physicians per 1000 inhabitants) were taken from the World Bank online
database. But for a few exceptions, they range from 2010 to 2012. The correlation between
physician density and GDP p.c. is not strong enough to prevent the use of both variables as
regressors (see Table A2). 
We avoided transforming the variables into logarithms since this practice, although
common, has been shown to be theoretically weak (Mayumi and Giampietro, 2010).
Nonetheless, we verified that using logs does not change the results qualitatively.
3.4. Countries
The GLOBOCAN 2012 dataset covers 184 Countries. We excluded those countries (33)
for which data were estimated by merely imputing the data of neighbouring countries or
registries in the same area. Of the 151 remaining countries, we excluded 5 that are not
included in the World Bank online database from which we took per capita income1. We also
excluded 18 countries for which 20 year lagged p.c. income or other data were not available.
Our final list, presented in the appendix, included 122 countries since six other countries were
considered outliers and removed. 
As discussed in econometrics textbooks (e.g. Gujarati 2004, 540 ff.), including or
excluding outliers is a tricky issue. An outlier differs markedly from the other observations
and, hence, “provides a large residual when the chosen model is fitted to the data” (Draper and
John 1981, 21). An outlier must be excluded if it is influential, that is, distorting the slope of
the regression line or even forcing the researcher to change the model specification. This
problem is particularly serious in semiparametric models since “GAMs can be very sensitive to
the presence of a small proportion of observations that deviate from the assumed model. In
other words: a few atypical observations could seriously affect the non-parametric estimates
of the smooth regression function” (Azadeh and Salibian-Barrera, 2011).  
A preliminary check on the dataset (see Figure A1) shows that there are some
observations that are potentially influential (due to their very high income levels) and for
which one can easily imagine that they will have large regression residuals for any
1 State of Palestine, France Guadeloupe, France La Reunion, France Martinique, and France Guyana.
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specification that can be conceived. One notices that the observations in question refer to two
very small and atypical countries, Singapore (a city-state with a rather idiosyncratic economy)
and Luxembourg (whose economy is based on financial services), and to another 5 countries
whose economy is strongly based on oil exports2. Their special characteristics are such that
other countries cannot be thought to mimic their performances. For a formal check of
influential observations and outliers we followed the approach developed by Fox (2008)3,
which is based on studentized residual, hat-values and Cook’s distances. Applying it to several
model specifications (the linear model and those described in section 4), we found that the 5
“oil” countries and Luxembourg should be excluded, while excluding Singapore is not
statistically supported. 4
3.5 Data descriptive statistics
A preliminary overview of the data is given by Table A1, which contains the main descriptive
statistics for the variables. Table A2 shows the correlation matrix for all-sites cancers, both for
the entire population and for the age class 40-60, p.c. income (and its lagged values), and
physician density. As expected the autocorrelation of p.c. income is remarkably high.
4. Results
We start by presenting the results for all cancers, and then we move to organ site-specific
cancers.  The labels of the variables are as follows. AllC refers to incidence rates for all cancers,
otherwise the name of site-specific cancer is indicated.  The suffix “_40-60” indicates that the
rate refers to the population in the age class 40-60. Incidence rates are measured as yearly
new cases on 100,000 inhabitants. Y_92 is the three-year average, centred on the year 1992, of
GDP p.c. (thousands of $PPP2011) and PhysD is the physician density in 2012 (number of
physicians every 1000 inhabitants).
The semiparametric analysis for all cancers is shown in Figures 2a and 2b. Regressing
the incidence rate on p.c. income gives the concave curve that is shown in Figure 2a. However,
when controlling for physician density, the marginal impact of p.c. income on cancer incidence
becomes linear (the straight line in Figure 2a), while the marginal impact of physician density
is non-linear (Figure A2). Similar results (not shown) are obtained when analysing the 40-60
age class. Figure 2b shows the confidence bands (5%) of the regression shown in Figure 2a.
2 Bahrain, Brunei, Oman, Saudi Arabia, United Arab Emirates.
3 The approach is also described in Levshina (2015, 153-155). We used the influencePlot function in the R-Package ‘car’
(https://cran.r-project.org/web/packages/car/car.pdf).
4 It is worth noticing that including the 5 “oil” countries requires changing the model specification, while Luxembourg affects
only the size of the estimated coefficients.
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Figure 2a. Standardised cancer incidence rates in 2012 vs. p.c. income in 1992. Semiparametric fits
when controlling (straight line) and not controlling (curve) for physician density. Age classes: whole
population. 
 
Figure 2b. Standardised cancer incidence rates in 2012 vs. p.c. income in 1992. Semiparametric fits
with confidence bands (5%) when not controlling (left) and controlling (right) for physician density.
Age classes: whole population.
This preliminary evidence, as discussed in detail in section 3.2, was helpful to specify
the parametric estimates, which, in contrast to the semiparametric estimates, also allow the
possible spatial correlation of errors to be taken into account.
The results of the SEM parametric regressions for all cancers are shown in Table 1. Let
us start from the first three equations. Equations 1a and 1b refer to the whole population,
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while equation 2 concerns the age class 40-60. In equation 1a income is 20 years lagged, while
in eq. 1b income has no lag. The two estimates are very similar. As already mentioned (see
3.1), this is due to the high autocorrelation of income, and also holds for estimates referring to
other time lags. All estimates show that the incidence rates for all cancers are positively
correlated with p.c. income even when controlling for population ageing, physician density
and omitted spatially correlated covariates. Standardised incidence rates increase by 4.66 and
by 0.64, respectively for all ages (eq. 1a) and for the age class 40-60 (eq. 2), per increase in p.c.
income of 1,000$ (1992, PPP2011). Figure 3 and Figure A3 show the marginal impact on
standardised incidence rates of p.c. income, drawn respectively for the whole population (eq.
1a) and for the 40-60 age class (eq. 2). It should be noted that p.c. income coefficients may
partially capture differences in detection/reporting capacity that cannot be accounted for in
terms of physician density. However, as Figure 2 suggests, there are no reasons for believing
that including a better proxy would transform the relationship from linear to concave .
Table 1. Summary of the Spatial Error Model parametric estimates1
Dep. Var.
AllC = 108.8 + 4.66  
Y_92
+ 47.9
4
 PhysD - 6.09  PhysD
2
[Eq. 1a]
s.e. 9.71 0.81 8.35 1.41
p. <0.001 <0.00
1
<0.00
1
<0.001
AdjR2=0.76; Spatial parameter=0.47, p<0.001
AllC = 107.06 + 2.20 Y_12 + 46.06 PhysD - 5. 860 PhysD2 [Eq. 1b]
s.e. 0.60 0.34 8.06 1.36
p. <0.001 <0.001 <0.001 <0.001
AdjR2=0.78; Spatial parameter=0.49, p<0.01
AllC_40-
60
= 40.05 + 0.64  
Y_92
+ 18.5
7
 PhysD - 2.47  PhysD
2
[Eq. 2]
s.e. 3.30 0.29 2.97 0.50
p. <0.001 <0.00
1
<0.00
1
<0.001
AdjR2=0.58; Spatial parameter=0.41, p<0.01
AllC = 130.93 + 11.9
4
 
Y_92
- 0.24  Y_92 2 [Eq. 3]
s.e. 12.04 2.31 0.10
p. <0.001 <0.00
1
  0.01
5
AdjR2=0.72; Spatial parameter=0.58, p<0.01; calculated turning point Y_92=25.402
1 Results are rounded to two decimal places.
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Summary
statistics of the
observed values:
Min Mean Max
AllC 61.8 196.3 374.1
AllC_40-60 18.3 64.7 115.2
Y_92 0.251 7.266 27.352
PhysD 0.02 1.80 6.72
The contribution of physician density to the fitted incidence rates is measured by the
corresponding terms of Equations 1a and 2 and can be visualised by Figure 4 and Figure A4,
drawn respectively for the whole population and for the 40-60 age class. For both regressions,
the impact is positive and increasing only up to roughly 3.8 physicians over 1000 inhabitants.
Further increases in physician density beyond this value cannot be assessed since very few
countries surpass it and the confidence bands become very wide. Similar behaviour emerged
in all the other regressions where physician density was significant.
igure 3. Marginal impact (and 95% confidence band)
of p.c. income. 
(Parametric regression of standardized incidence of
all-sites cancers on p.c. income and physician
density. Age class: all population). 
igure 4. Marginal impact (and 95% confidence
band) of physician density. 
(Parametric regression of standardized incidence of
all-sites cancers on p.c. income and physician
density. Age class: all population). 
Equation 3 is shown only to illustrate the effect of not controlling for physician density,
which however involves mis-specification. Given that the semiparametric fit (see Figure 2)
was non linear, by minimizing AICc  we found that in this case the best specification for
income was quadratic. The fitted curve has an inverted-U shape. The reason is that the
quadratic term in equation (3) partially captures that which in equation (1) is captured by
physician density. The estimated relationship is increasing within almost the entire range of
the observed income values since the calculated turning point (25,402$) is close to the highest
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p.c. income (27,352$) (see Table 1). Not controlling for physician density yields similar
consequences in all the other regressions for which the estimated relationship between
income and cancer was positive. 
The analysis presented above was replicated for most common site-specific cancers.
Table 2 and Table A3 in the appendix, referring respectively to all age classes and to the 40-60
age group, summarise the main results. They are organised as follows. Organ site-specific
cancers are ordered according to their relative frequency, which is shown in the second
column. The third column indicates whether, according to the health literature (see below) the
cancer organ site is typical of high-income countries (H) or low/medium income (M-L) ones.
Notice that the most frequent organ-site cancers are also typical of high-income countries. The
fourth column gives a concise indication of the shape of the estimated relationship while the
fifth column indicates whether the estimated income coefficient is positive, negative, non-
significant, or follows an EKC shape. The sixth column shows whether the estimated effect of
physician density is positive or concave (+), negative (-), or non-significant (n.s). The seventh
and eighth columns give the values of the income coefficients and their significance level,
while the ninth shows the adjusted R-squared. Full results are in the appendix, Table A4.
The prevalence of different organ sites cancer according to the level of development is
well established (e.g. Newby et al. 2005; Stewart et al 2014). Lung, breast, colorectum and
prostate cancers are the most common organ sites in developed countries, associated both
with lifestyles and with environmental factors (Howard and Staats, 2013). Liver, stomach,
oesophagus and cervix uteri are highly correlated to chronic infection (such as hepatitis B
virus, human papillomaviruses and Helicobacter pylori), which are more common in
low/medium income countries. 
When regressing incidence rates on GDP p.c., the sign of the coefficient should be
negative for organ-sites typical of low-income countries, and positive (or EKC shaped) for
cancers typical of high income countries. This is because increase in GDP in low-income
countries improves overall hygiene conditions and thus reduces cancer incidence associated
with chronic infection types of cancers. In contrast, in high-income countries an increase in
GDP leads to an increase of environmental pollutants and xenobiotic substances and adoption
of “western” type life-styles that bring an overall increase in cancer incidence (see discussion
in section 2). 
Our regressions confirmed the expected typicality for developed or LDC countries (see
the signs of the income coefficients in Table 2). Results also highlighted that colorectum
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cancer is the only one among the most frequent organ-site cancers that follows an EKC shape,
although the curve turns down only at rather high levels of p.c. income (at 22,890  1992$ GDP
p.c.). The external risk factors associated with this organ cancer are mainly life-style factors,
namely diets that are high in red and processed meats, habitual inactivity, alcohol use, and
tobacco smoking. The latter is the most important risk factor for developing lung cancer;
however, several environmental and occupational exposures have also been found to be
relevant, explaining globally 36% of lung cancer (Prüss-Üstün, 2016, 50).  The composition of
smoking with other exposures could explain the linearity of the pattern for lung cancer. The
environmental risks that are positively associated with income could have offset the beneficial
effects of the reduction of cigarette smoking that occurred in many high-income countries (see
Stewart et al., 2014).
The colorectum and lung cases highlight the finding that differences in relative
frequency between developed and less developed countries (LDCs) do not imply that
environmental factors are irrelevant in the organ-site cancers typical of LDCs. For instance,
ionizing radiations, exposure in the rubber industry and to asbestos are also risk factors of
stomach cancer. Among the sites that we considered, the prostate, the cervix, and the liver are
likewise associated with environmental factors (Prüss-Üstün, 2016, 46-51), although the first
is typical of high-income countries while the latter two are most frequently found in low-
income areas. 
In any case, disentangling the environmental effects is difficult since, for each organ site
cancer, occurrence is affected by several risk factors that differ according to income.  Hence,
the actual shape of relationship between income and incidence depends on the relative
strength of the various contrasting effects. 
Two further remarks can be made. First, physician density  was found to be negatively
correlated with cervix uteri cancer, which is consistent with the importance of physicians in
fostering prevention, and hence reducing incidence rates of this organ site cancer. Second, the
estimates for the different organ-site cancers help to understand why a positive relationship
with income emerges at the overall level. The reason is that the cancers for which a negative
relationship with income holds are less frequent than those for which the relationship is
positive. 
Table 2. Summary of the Spatial Error Model estimates for the 8 most common organ-site
cancers , all age classes
1 2 3 4 5 6                 7 8 9
Organ Site
Rel. 
freq.
Typical
of
Model
Role of
Y_92
Role of
PhysD
Y_92
coeff.
Y_922
coeff.
Adj
RSq
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434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
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Lung 13.0% H Linear + + 0.41**  0.61
Breast 11.9% H Linear + + 1.89*** 0.70
Colorectum 9.7% H EKC § + 2.25*** -0.049*** 0.76
Prostate 7.9% H Linear + n.s. 2.43*** 0.75
Stomach 6.8% L/M Linear - + -0.37*** 0.36
Liver 5.6% L/M Linear - n.s. -0.36**  0.08
Cervix uteri 3.7% L/M Linear - - -0.39^   0.48
Oesophagus 3.2% L/M None none n.s. n.s. 0.28
H: High-income countries, L/M: low/medium income countries
Significance levels: **: p<0.05, ***: p<0.01, ^: 0.11; n.s.: non-significant
§ calculated turning point = 22,890 $ GDP 1992PPP
Finally, the estimated coefficient of the spatial dependence in the error term was
positive and significant in all regressions, confirming the relevance of omitted geographically
correlated factors.
5. Conclusion
The evidence presented in this paper can be compared with the results of three previous
studies, already mentioned in the introduction, the primary goal of which, however, was not to
explore the relationship between cancer incidence and income growth. Beaulieu et al. (2009)
used a methodology similar to ours, that is, they focused on p.c. income and performed a
regression analysis. In contrast to us, they controlled for the effect of population ageing by
including in the regressions the percentage of population aged 65; additionally, they used
intercept dummies to control for geographical differences, but did not control for non-linear
influences of income and for cancer reporting improvements. Moreover, they did not use time
lags for income. Finally, they had to produce their own estimates of incidence rates, based on
GLOBOCAN data for 2002, while we were able to use more reliable and recent data (2012).
Hence, their results are not fully comparable with ours. Beaulieau and colleagues interpreted
the positive relationship between incidence rates and income as an expected outcome of
underreporting cancer cases in developing countries. We show that the positive relationship
does not disappear when controlling for physician density, taken as a proxy for incidence
reporting.  On the contrary, our data and analysis suggest a higher effect of income on cancer
incidence rates: in Beaulieau et al. (2009, 63) the income coefficient is equal to 1.457, with a
95% confidence interval of  [0.50; 2.4], while ours is equal to 4.66 (see equation 1a), with 95%
C.I. of [3.06; 6.26] 
Bray et al. (2012) and Fidler et al. (2016) did not use regression analysis or income as a
key variable: rather, they compared four groups of countries pooled according to the level of
HDI. This could be problematic because of ex-ante defined groups and because HDI also
includes life expectancy, which should, instead, be a control variable. In any case, their design
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is too different to allow for a close comparison of the results. Nonetheless, it can be noticed
that their papers likewise found both a positive relationship of incidence with levels of
development, and different patterns for different cancer sites when comparing less developed
and developed countries. 
Overall, our results are in line with previous evidence, which is not only updated but
also strengthened because of the use of a different methodology. Our regressions, which
explain a substantial part of the variability (in most cases adjusted R-squared values are
higher than 0.6), showed that the relationship between income and cancer incidence rate
remains positive (and significant) even after controlling both for favourable effects of
economic development - namely population ageing and improvements in cancer detection and
statistical reporting - and for spatially correlated omitted variables.  
Another result of this work is that underreporting can be proxied by a concave function
of physician density, the contribution of which is positive and increasing up to roughly 3.8
physicians over 1000 inhabitants, while further increases do not seem to be relevant. Only for
cervix uter cancer did physician density result to be negatively correlated. This should not be
surprising since prevention is particularly important for cervix uter cancer and physicians
play a key role in prevention. Finally, omitting to control for physician density would produce
in some cases inverted-U patterns, with turning points at the very end (or beyond) of the
income range of the sample. Such an omission, however,  was regarded here as a
misspecification.
To sum up, our analysis shows that the cancer epidemic cannot be explained solely by
higher life expectancy, by better statistics and by regional peculiarities: rather, a significant
role must also be attributed to environmental degradation and life-styles. Unfortunately, our
regressions are unable to distinguish between the two. Some clues can be drawn from the case
of lung cancer, which, despite the decrease in smokers in high-income countries, still exhibits a
positive relationship with income rather than a Kuznets curve. This could be interpreted as
arising from environmental exposure. In any case, due to the presence of so many confounding
factors, separating the environmental effects from the life-style aspects would require either
using micro data or restricting the analysis to units for which a considerable range of statistics
is available. 
However, the relevance of environmental risk factors can be inferred from the
increasing evidence available from the health literature according to which “environmental
factors play a more important role in cancer genesis than it is usually agreed” (Irigaray 2007,
640). Our findings are consistent with this literature, namely, that both social change (e.g.
18
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
48
lifestyles) and “the involuntary exposure to many carcinogens in the environment contributes
to the rising trend in cancer incidence” (Belpomme et al. 2007a, 1037).
 The policy message that can be drawn from our work is that only by becoming aware
of the negative side effects of economic development will we also be able to implement
policies to tackle them.  This is the message of one of the most important recent reports on
cancer, according to which “the realization of just how much disease and ill health can be
prevented by focusing on environmental risk factors should add impetus to global efforts to
encourage preventive health measures” (Prüss-Üstün, 2016, VII).
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